Publications by authors named "Hasan Alhasani"

Claim this Profile
R
Real-world treatment and outcomes for EGFR WT advanced/metastatic non-squamous non-small cell lung cancer: pooled analysis from project LUMINATE-101.
Nicolas Girard, Qingqing Xu, D Ross Camidge, Shobhit Baijal, Sophia Ng, Hasan Alhasani

Oncologist· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world comparative effectiveness of venetoclax-obinutuzumab versus Bruton tyrosine kinase inhibitors for frontline chronic lymphocytic leukaemia.
Nilanjan Ghosh, Beenish S Manzoor, Bita Fakhri, Nnadozie Emechebe, Hasan Alhasani

Br J Haematol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Health Care Resource Use and Costs Among Patients With Chronic Lymphocytic Leukemia Treated With Venetoclax-Based and Bruton Tyrosine Kinase Inhibitor-Based Regimens in the Second-Line Setting.
Bita Fakhri, Nnadozie Emechebe, Beenish S Manzoor, Dureshahwar Jawaid, Hasan Alhasani

JCO Oncol Pract· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world adherence and discontinuation among Medicare beneficiaries initiating venetoclax vs. BTKis in relapsed/refractory chronic lymphocytic leukemia.
Scott F Huntington, Beenish S Manzoor, Justin T Puckett, Sachin Kamal-Bahl, Hasan Alhasani

Leuk Lymphoma· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment Discontinuation Patterns for Patients With Chronic Lymphocytic Leukemia in Real-World Settings: Results From a Multi-Center International Study.
Mazyar Shadman, Beenish S Manzoor, Kavita Sail, Hande H Tuncer, John N Allan, Hasan Alhasani

Clin Lymphoma Myeloma Leuk· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MAJIC: a phase III trial of acalabrutinib + venetoclax versus venetoclax + obinutuzumab in previously untreated chronic lymphocytic leukemia or small lymphocytic lymphoma.
Christine E Ryan, Matthew S Davids, Richard Hermann, Mina Shahkarami, Juliana Biondo, Hasan Alhasani

Future Oncol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of an external ventricular drain bundle and limited duration antibiotic prophylaxis on drain-related infections and antibiotic resistance.
Colleen Whyte, Hasan Alhasani, Richard Caplan, Andrea P Tully

Clin Neurol Neurosurg· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis